Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABEONA THERAPEUTICS INC. Director's Dealing 2021

Oct 8, 2021

33413_dirs_2021-10-08_43a18293-7db4-4e9c-b9af-b42479e1a07b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABEONA THERAPEUTICS INC. (ABEO)
CIK: 0000318306
Period of Report: 2021-10-07

Reporting Person: Wider Todd (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-10-07 Common Stock S 25000 $0.966 Disposed 0 Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.9624 to $0.9661, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.